Lipocine Inc

LPCN NASDAQ Santé & Biotech États-Unis US53630X1046
2.08 $
5.25 %

Lipocine Inc se concentre sur le développement clinique de médicaments hormonaux pour les thérapies de remplacement de la testostérone.

Performance & Momentum

6 Months 34.13 %
1 Year 33.54 %
3 Years 53.48 %
5 Years 90.82 %

Similar stocks to Lipocine Inc

Anantys Community

Be the first to share your analysis on Lipocine Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases